We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
-5.31%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$10.6B
AUM Growth
-$1.48B
Cap. Flow
-$963M
Cap. Flow %
-9.05%
Top 10 Hldgs %
19.75%
Holding
927
New
168
Increased
168
Reduced
125
Closed
420
Avg Time Held Equity + Options
2 quarters
Top 10 Avg Time Held Equity + Options
1 quarter
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
2.1 quarters
Top 10 Avg Time Held Equity only
1 quarter
Top 20 Avg Time Held Equity only
1.5 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 17.42%
2 Industrials 17.11%
3 Financials 12.81%
4 Consumer Discretionary 12.17%
5 Consumer Staples 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NTAP icon
401
NetApp
NTAP
$46.9B
$960K 0.01%
32,444
-4,312
-12% -$133K
2015 Q2
1 quarter
DERM icon
402
DELISTED
Dermira, Inc.
DERM
$942K 0.01%
40,400
-159,600
-80% -$3.88M
2014 Q4
3 quarters
ORBC
403
DELISTED
ORBCOMM, Inc.
ORBC
$942K 0.01%
168,686
+148,686
+743% +$895K
2014 Q4
3 quarters
MHO icon
404
M/I Homes
MHO
$3.19B
$926K 0.01%
+39,232
New +$974K
2015 Q3
0 quarters
RKDA icon
405
Arcadia Biosciences
RKDA
$500K
$922K 0.01%
378
-186
-33% -$774K
2015 Q2
1 quarter
TMHC icon
406
DELISTED
Taylor Morrison
TMHC
$896K 0.01%
+48,036
New +$949K
2015 Q3
0 quarters
CDTX icon
407
DELISTED
Cidara Therapeutics
CDTX
$842K 0.01%
3,311
– –
2015 Q2
1 quarter
SIEN
408
DELISTED
Sientra, Inc.
SIEN
$812K 0.01%
8,000
-626
-7% -$142K
2014 Q4
3 quarters
CLCD
409
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$780K 0.01%
201,588
-11,912
-6% -$88K
2015 Q2
1 quarter
ATRA icon
410
Atara Biotherapeutics
ATRA
$93.4M
$734K 0.01%
+934
New +$1.14M
2015 Q3
0 quarters
ATRS
411
DELISTED
Antares Pharma, Inc.
ATRS
$680K 0.01%
400,000
-800,000
-67% -$1.57M
2015 Q2
1 quarter
INVN icon
412
DELISTED
Invensense Inc
INVN
$650K 0.01%
+70,000
New +$786K
2015 Q3
0 quarters
KPTI icon
413
Karyopharm Therapeutics
KPTI
$9.69M
$632K 0.01%
+4,000
New +$1.07M
2015 Q3
0 quarters
ADMA icon
414
ADMA Biologics
ADMA
$2.31B
$608K 0.01%
72,800
– –
2015 Q1
2 quarters
COKE icon
415
Coca-Cola Consolidated
COKE
$12.9B
$588K 0.01%
30,380
+2,120
+8% +$34.5K
2015 Q1
2 quarters
GOL icon
416
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$574K 0.01%
294,324
-33,176
-10% -$97.4K
2015 Q1
2 quarters
JOYY icon
417
JOYY Inc
JOYY
$4.04B
$564K 0.01%
+10,326
New +$596K
2015 Q3
0 quarters
OOMA icon
418
Ooma
OOMA
$557M
$556K 0.01%
+80,000
New +$749K
2015 Q3
0 quarters
UAA icon
419
PUT
Under Armour
UAA
$2.1B
$554K 0.01%
+224,000
New +$10.6M
2015 Q3
0 quarters
SPY icon
420
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$552K 0.01%
850,000
+700,000
+467% +$142M
2014 Q4
3 quarters
VTVT icon
421
vTv Therapeutics
VTVT
$112M
$522K ﹤0.01%
+2,000
New +$697K
2015 Q3
0 quarters
P icon
422
DELISTED
Pandora Media Inc
P
$510K ﹤0.01%
23,878
-482,642
-95% -$8.47M
2015 Q1
2 quarters
LULU icon
423
CALL
lululemon athletica
LULU
$10.9B
$492K ﹤0.01%
+224,000
New +$13.7M
2015 Q3
0 quarters
OESX icon
424
Orion Energy Systems
OESX
$101M
$482K ﹤0.01%
26,764
-3,236
-11% -$68.5K
2015 Q1
2 quarters
BLDP icon
425
Ballard Power Systems
BLDP
$621M
$480K ﹤0.01%
+400,000
New +$543K
2015 Q3
0 quarters

Similar funds

UBS O'Connor's Q3 2015 Portfolio in Review

As of Q3 2015, UBS O'Connor held 927 positions worth $10.6B, down 12% from $12.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

UBS O'Connor withdrew a net $963M in Q3 2015, closing 420 positions and reducing 125 holdings. Its most notable exit was FAMILY DOLLAR STORES, an estimated $390M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, UBS O'Connor opened a new position in PayPal worth $164M.

  • UBS O'Connor's largest Q3 2015 buy was PayPal: 5,293,436 shares worth $164M.
  • UBS O'Connor added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $218M increase.
  • UBS O'Connor's biggest Q3 2015 reduction was Coca-Cola Europacific Partners, cutting an estimated $92.5M.
  • UBS O'Connor fully exited FAMILY DOLLAR STORES in Q3 2015, selling an estimated $390M.
  • UBS O'Connor's ten largest holdings make up 20% of its $10.6B portfolio in Q3 2015.
  • UBS O'Connor opened 168 new positions and closed 420 in Q3 2015.
  • UBS O'Connor's portfolio value fell 12% quarter-over-quarter to $10.6B.

Based on UBS O'Connor's 13F filing for Q3 2015, filed 13 Nov 2015.